BullFrog AI Holdings (BFRG) Payables (2021 - 2026)
BullFrog AI Holdings' (BFRG) quarterly Payables came in at $169945.0 in Q2 2026, down 41.82% on a YoY basis from $292084.0 in Q2 2025, and up 1.07% quarter-over-quarter from $168151.0 in Q4 2025.
Analysis
BullFrog AI Holdings (BFRG) Payables (2021 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRG) has reported Payables for 6 consecutive years, with $169945.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Payables fell 41.82% year-over-year to $169945.0; the trailing twelve-month figure through Jun 2026 stood at $169945.0 (down 41.82% YoY), and the FY2025 full-year result was $168151.0, down 61.43% from the prior year.
- Payables grew to $169945.0 in Q2 2026 per BFRG's latest filing, from $168151.0 in the prior quarter.
- Across five years, Payables topped out at $1.3 million in Q1 2023 and bottomed at $103656.0 in Q4 2023.
- Historically, Payables has averaged $458507.1 across 5 years, with a median of $349198.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Payables plunged 87.02% in 2023, then surged 320.56% in 2024.
- Over 5 years, Payables stood at $798843.0 in 2022, then slumped by 87.02% to $103656.0 in 2023, then soared by 320.56% to $435934.0 in 2024, then tumbled by 61.43% to $168151.0 in 2025, then climbed by 1.07% to $169945.0 in 2026.
- According to Business Quant data, Payables over the past three periods registered $169945.0, $168151.0, and $223818.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 428.93 Mn |
| 10 | BullFrog AI Holdings | 9.27 Mn | 2.35 Mn | 106,899.00 | 169,945.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 169,945.00 |
| Dec 31, 2025 | 168,151.00 |
| Sep 30, 2025 | 223,818.00 |
| Jun 30, 2025 | 292,084.00 |
| Mar 31, 2025 | 374,603.00 |
| Dec 31, 2024 | 435,934.00 |
| Sep 30, 2024 | 263,379.00 |
| Jun 30, 2024 | 423,056.00 |
| Mar 31, 2024 | 661,696.00 |
| Dec 31, 2023 | 103,656.00 |
| Sep 30, 2023 | 323,793.00 |
| Jun 30, 2023 | 913,765.00 |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 798,843.00 |
| Dec 31, 2021 | 471,817.00 |